Carisma Therapeutics Inc. Annual Operating Lease, Payments in USD from 2018 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: Carisma Therapeutics Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2023.
Carisma Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.46M, a 1.04% increase year-over-year.
Carisma Therapeutics Inc. annual Operating Lease, Payments for 2023 was $5.76M, a 21.3% increase from 2022.
Carisma Therapeutics Inc. annual Operating Lease, Payments for 2022 was $4.75M.
Carisma Therapeutics Inc. annual Operating Lease, Payments for 2021 was $0.000.

Operating Lease, Payments, Annual (USD)

Operating Lease, Payments, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$5.76M	+$1.01M	+21.3%	Jan 1, 2023	Dec 31, 2023	10-K	2024-04-01
2022	$4.75M	+$4.75M		Jan 1, 2022	Dec 31, 2022	10-K	2024-04-01
2021	$0	$0		Jan 1, 2021	Dec 31, 2021	10-K	2022-02-28
2020	$0	-$236K	-100%	Jan 1, 2020	Dec 31, 2020	10-K	2022-02-28
2019	$236K	+$236K		Jan 1, 2019	Dec 31, 2019	10-K	2022-02-28
2018	$0			Jan 1, 2018	Dec 31, 2018	10-K	2021-03-15

Showing 1 to 6 of 6 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.